Welcome to Xi’an Good Doctor Medical Science and Technology Co., Ltd.website ！
Internet Drug Information Service Qualification Certificate: (Shaanxi)-Non-Operating -2023-0143
In the past two years, the use of constant temperature circulating perfusion for intraperitoneal and venous double-route hyperthermic chemotherapy has achieved satisfactory results in preventing and treating intraperitoneal metastatic cancer, which cannot be achieved by non-circulating hyperthermic perfusion chemotherapy. This article analyzes and compares the mechanisms, feasibility, treatment methods, and efficacy of intraperitoneal circulating and non-circulating hyperthermic perfusion chemotherapy based on clinical observations and literature reports.
2022-08-26
Discuss the efficacy of intraperitoneal hyperthermic chemotherapy after surgery for gastrointestinal malignancies. Method: Select 60 patients with stage II to IV gastrointestinal malignancies after surgery, with 32 cases as the treatment group receiving intraperitoneal hyperthermic chemotherapy + intravenous chemotherapy, and 28 cases as the control group receiving conventional intravenous chemotherapy. Results: The intraperitoneal recurrence rate and metastasis rate in the treatment group were significantly lower than those in the control group (P
2022-08-26
Clinical analysis of 110 cases of gastric cancer peritoneal carcinoma treated with tumor cell reduction surgery combined with intraperitoneal hyperthermic chemotherapy.
2022-08-26
Expert Consensus on Tumor Cell Reduction Surgery Combined with Intraperitoneal Hyperthermic Chemotherapy for Pseudomyxoma Peritonei
2022-08-26
Safety Experimental Study of Intraperitoneal Circulation Hyperthermic Perfusion Chemotherapy - Liu Wenchao 2012 (Li Wei) Safety Experimental Study of Intraperitoneal Circulation Hyperthermic Perfusion Chemotherapy - Liu Wenchao 2012 (Li Wei) Safety Experimental Study of Intraperitoneal Circulation Hyperthermic Perfusion Chemotherapy - Liu Wenchao 2012 (Li Wei)
2022-08-26
Expert consensus on cytoreductive surgery combined with intraperitoneal hyperthermic chemotherapy for peritoneal surface tumors
2022-08-26
A Controlled Study of Intracavitary Constant Temperature Circulating Thermal Perfusion Chemotherapy for Malignant Pleural Effusion - Wang Liufei 2010 (Li Wei)
2022-08-26
Objective: To explore the efficacy of continuous circulating hyperthermic intraperitoneal chemotherapy (HIPEC) at a temperature of 42-43°C for malignant ascites. Method: 45 patients with malignant ascites were randomly divided into two groups. The observation group consisted of 22 patients who underwent conventional puncture to establish a double-channel circulation, first performing peritoneal lavage to replace the intraperitoneal perfusion fluid, and finally maintaining 2500-3500 ml. The continuous circulation at a temperature of 42-43°C began 3-5 minutes later.
2022-08-26
Understanding the Main Characteristics of Cancer Cells in Tumor Knowledge
A tumor (tumor, neoplasm) is a genetic disease, but it is not hereditary; it refers to the change in genes under the influence of tumorigenic factors, losing normal regulation of its growth, leading to abnormal proliferation. It can be divided into two main categories: benign and malignant tumors.
2022-08-26
· China Good Doctor ·
· Good friends of human beings ·
Address: Floor 1-2, Left Building No. 1, Huoju Road, East zone of Xi’an High- tech Development District, Xi’an, China
Copyright Xi'an Good Doctor Medical Technology Co., Ltd.
Internet Drug Information Service Qualification Certificate (Shaanxi)-Non-Operating -2023-0143